Llorca, P., Lançon, C., Brignone, M., Painchault, C., Rive, B., Toumi, M., & François, C. (2015). Can we well assess the relative efficacy and tolerability of a new drug versus others at the time of marketing authorization using mixed treatment comparisons? A detailed illustration with escitalopram. J Mark Access Health Policy.
Čikaški stil citiranjaLlorca, Pierre-Michel, Christophe Lançon, Mélanie Brignone, Caroline Painchault, Benoit Rive, Mondher Toumi, i Clément François. "Can We Well Assess the Relative Efficacy and Tolerability of a New Drug Versus Others At the Time of Marketing Authorization Using Mixed Treatment Comparisons? A Detailed Illustration With Escitalopram." J Mark Access Health Policy 2015.
MLA način citiranjaLlorca, Pierre-Michel, et al. "Can We Well Assess the Relative Efficacy and Tolerability of a New Drug Versus Others At the Time of Marketing Authorization Using Mixed Treatment Comparisons? A Detailed Illustration With Escitalopram." J Mark Access Health Policy 2015.